AXSOME THERAPEUTICS, INC. Shares Outstanding (Cover Page)
AXSOME THERAPEUTICS, INC. (AXSM) had Shares Outstanding (Cover Page) of 52.38 million shares as of 2026-08-03, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-03: Entity Common Stock, Shares Outstanding 52.38M shares.
- 2026-04-27: Entity Common Stock, Shares Outstanding 51.46M shares.
- 2026-02-16: Entity Common Stock, Shares Outstanding 51.15M shares.
- 2025-10-27: Entity Common Stock, Shares Outstanding 50.41M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 52.38M shares 10-Q · filed 2026-08-10 |
| 2026-04-27 | 51.46M shares 10-Q · filed 2026-05-04 |
| 2026-02-16 | 51.15M shares 10-K · filed 2026-02-23 |
| 2025-10-27 | 50.41M shares 10-Q · filed 2025-11-03 |
| 2025-07-28 | 49.90M shares 10-Q · filed 2025-08-04 |
| 2025-04-28 | 49.24M shares 10-Q · filed 2025-05-05 |
| 2025-02-11 | 48.77M shares 10-K · filed 2025-02-18 |
| 2024-11-05 | 48.46M shares 10-Q · filed 2024-11-12 |
| 2024-07-29 | 48.00M shares 10-Q · filed 2024-08-05 |
| 2024-04-29 | 47.50M shares 10-Q · filed 2024-05-06 |
| 2024-02-13 | 47.37M shares 10-K · filed 2024-02-23 |
| 2023-10-31 | 47.32M shares 10-Q · filed 2023-11-06 |
| 2023-07-31 | 47.19M shares 10-Q · filed 2023-08-07 |
| 2023-05-01 | 43.57M shares 10-Q · filed 2023-05-09 |
| 2023-02-21 | 43.52M shares 10-K · filed 2023-02-28 |
| 2022-10-31 | 43.43M shares 10-Q · filed 2022-11-07 |
| 2022-08-01 | 40.30M shares 10-Q · filed 2022-08-09 |
| 2022-04-26 | 38.91M shares 10-Q · filed 2022-05-02 |
| 2022-02-22 | 38.48M shares 10-K · filed 2022-03-01 |
| 2021-11-01 | 37.69M shares 10-Q · filed 2021-11-08 |
| 2021-08-02 | 37.68M shares 10-Q · filed 2021-08-09 |
| 2021-05-03 | 37.57M shares 10-Q · filed 2021-05-10 |
| 2021-02-22 | 37.41M shares 10-K · filed 2021-03-01 |
| 2020-10-30 | 37.34M shares 10-Q/A · filed 2020-11-06 |
| 2020-08-03 | 37.28M shares 10-Q · filed 2020-08-10 |
| 2020-05-01 | 37.08M shares 10-Q · filed 2020-05-11 |
| 2020-03-06 | 37.08M shares 10-K · filed 2020-03-12 |
| 2019-11-01 | 34.51M shares 10-Q · filed 2019-11-07 |
| 2019-08-02 | 34.42M shares 10-Q · filed 2019-08-08 |
| 2019-05-03 | 33.31M shares 10-Q · filed 2019-05-09 |
| 2019-03-11 | 33.28M shares 10-K · filed 2019-03-15 |
| 2018-11-02 | 29.81M shares 10-Q · filed 2018-11-09 |
| 2018-08-03 | 26.25M shares 10-Q · filed 2018-08-08 |
| 2018-05-04 | 25.69M shares 10-Q · filed 2018-05-08 |
| 2018-03-02 | 25.49M shares 10-K · filed 2018-03-07 |
| 2017-11-03 | 23.67M shares 10-Q · filed 2017-11-08 |
| 2017-08-04 | 23.61M shares 10-Q · filed 2017-08-09 |
| 2017-05-03 | 23.61M shares 10-Q · filed 2017-05-09 |
| 2017-03-02 | 19.20M shares 10-K · filed 2017-03-07 |
| 2016-11-09 | 19.15M shares 10-Q · filed 2016-11-14 |
| 2016-08-03 | 19.15M shares 10-Q · filed 2016-08-09 |
| 2016-05-03 | 19.15M shares 10-Q/A · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |